Oriola-KD to distribute Roche's pharmaceuticals in Finland

Oriola-KD Corporation Stock Exchange Release 29 November 2006 at 5.30 pm

Oriola-KD has signed an agreement with Roche Oy on the warehousing and delivery
of Roche's 
pharmaceuticals in Finland as of January 1, 2007. The market share of Roche in
the Finnish pharmaceutical market in January-October 2006 was 3.7 per cent
(Source: IMS Health). 

Roche is one of the fastest growing pharmaceutical companies in the industry
and it has a strong position especially in cancer treatment pharmaceuticals.
Roche Oy is the Finnish subsidiary of Swiss Roche Group. The group's net sales
in 2005 were about EUR 22.9 billion. 

Oriola-KD Corporation


Eero Hautaniemi          Henry Haarla
President and CEO      General Counsel


For additional information, contact:

Eero Hautaniemi
President and CEO
tel. +358 10 429 2109
email: eero.hautaniemi@oriola-kd.com

Pellervo Hämäläinen
Vice President, Corporate Communications and IR
tel. +358 10 429 2497
email: pellervo.hamalainen@oriola-kd.com

Distribution
Helsinki Stock Exchange
Principal media

Published by:
Oriola-KD Corporation
Corporate Communications
Harmaaparrankuja 1
FI-02200 Espoo
www.oriola-kd.com